ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2485

Quality of Evidence of the American College of Rheumatology (ACR) Clinical Practice Guidlines

Mushabab Alghamdi1 and Mohammed Al Mansour2, 1Internal Medicine, University of Bisha, Bisha, Saudi Arabia, 2Rheumatology, King Fahad Medical City, Riyadh, Saudi Arabia

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Best practices

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Quality Measures and Quality of Care Poster Session

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

The American College of Rheumatology (ACR) regularly establishes and publishes guidelines for the management of various rheumatic diseases. These guidelines assist physicians in providing appropriate care to patients afflicted with rheumatic diseases. The objective of this study is to evaluate the quality of evidence supporting recommendations in the  American College of Rheumatology (ACR) clinical practice guidelines.

Methods: Current guidelines for management of rheumatic diseases posted on the ACR website (http://www.rheumatology.org/) were evaluated using the methods reported by the American College of cardiology as follows: 1) for level of evidence A, data were derived from multiple RCTs or ameta-analysis, 2) for level B evidence, data were derivedfrom a single RCT or nonrandomized study, and 3) for level C evidence, data were derived from consensus, expert opinion, or case series.

Results:

At the time of our review, there were 7 guidelines posted on the ACR website, 5 of which were eligible for data analysis. Two guidelines were excluded ( not followed the same quality of evidence format ). The summary of the distribution is reported as the median of the percentage of all the eligible guidelines. The 5 analyzed guidelines contained a total of 191 recommendations, 56 were supported by Level A evidence (Median, 27.6(%); Inter-quartile range [IQR],15.4%-52.5%); 44 were supported by Level B evidence (Median, 18.9%; IQR,8.3%-33.8%); 91 were supported by Level C evidence (Median,45.2(%); IQR,33.2%-58.6%). (Table 1)

Table 1. Summary of All Current ACR Recommendations Level of Evidence, Number of recommendations (n), Percentage (%), Median (%) and Inter Quartile Range. 47.6% of the recommendation in the available website recommendation are supported by Level C evidence.

IQR

Median (%)

Percentage (%)

Number

Level of evidence

15.4%-52.5%

27.6

29.3

56

A

8.3%-33.8%

18.9

23.0

44

B

33.2%-58.6%

45.2

47.6

91

C

Conclusion: The ACR recommendations are supported mainly by level C evidence. These findings highlight the areas which have a paucity of high quality evidence and are not supported by either Level A or B evidence. The study highlights the limitations of current clinical rheumatological diseases research that can provide high quality of evidence. Support of high quality evidence research is crucially needed.


Disclosure: M. Alghamdi, None; M. Al Mansour, None.

To cite this abstract in AMA style:

Alghamdi M, Al Mansour M. Quality of Evidence of the American College of Rheumatology (ACR) Clinical Practice Guidlines [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/quality-of-evidence-of-the-american-college-of-rheumatology-acr-clinical-practice-guidlines/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/quality-of-evidence-of-the-american-college-of-rheumatology-acr-clinical-practice-guidlines/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology